Absci Corporation (ABSI) NASDAQ

4.28

-0.01(-0.23%)

Updated at October 23 04:00PM

Currency In USD

Absci Corporation

Address

18105 SE Mill Plain Boulevard

Vancouver, WA 98683

United States of America

Phone

360 949 1041

Sector

Healthcare

Industry

Biotechnology

Employees

156

First IPO Date

July 22, 2021

Key Executives

NameTitlePayYear Born
Mr. Sean McClainFounder, Chief Executive Officer, President & Director1.07M1990
Dr. Zachariah Jonasson Ph.D.Chief Business Officer & Chief Financial Officer813,3001973
Dr. Andreas Busch Ph.D.Chief Innovation Officer & Member of Scientific Advisory Board1.17M1963
Mr. Wen ShaChief of Staff0N/A
Mr. Todd Bedrick CPASenior Vice President & Chief Accounting Officer0N/A
Mr. Alexander Khan CPAVice President of Finance & Head of Investor Relations0N/A
Ms. Shelby Walker J.D.Chief Legal Officer01975
Dr. Christine Lemke D.V.M., M.B.A., Ph.D.Senior Vice President of Portfolio & Growth Strategy0N/A
Melissa Patterson Ph.D.Chief of Staff0N/A
Ms. Karin WierinckChief People Officer0N/A

Description

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.